Related Experiment Videos
Peripheral neuropathy after disulfiram administration: reversibility despite continued therapy
Drug and Alcohol Dependence
|October 1, 1982
Summary
This case study shows that paresthesias from disulfiram (an alcohol addiction medication) may improve with a lower dose and multivitamins, even with continued use. This challenges previous findings on disulfiram-induced neuropathy.
Area of Science:
- Neurology
- Pharmacology
- Toxicology
Background:
- Disulfiram is a medication used to treat alcohol dependence.
- Peripheral sensorimotor neuropathy is a known adverse effect of disulfiram.
- Neuropathy symptoms typically appear within weeks to months of disulfiram administration.
Observation:
- A patient developed paresthesias after one year of disulfiram treatment (250 mg daily).
- Symptoms improved despite continued disulfiram use at a reduced dosage (125 mg daily).
- Multivitamin supplementation was also administered concurrently.
Findings:
- This case contrasts with previous reports, showing symptom resolution with continued, lower-dose disulfiram and multivitamins.
- The patient's peripheral sensorimotor neuropathy resolved under this treatment regimen.
- This suggests a potential alternative management strategy for disulfiram-induced neuropathy.
Implications:
- This finding may offer a new approach to managing disulfiram-induced neuropathy, potentially avoiding drug discontinuation.
- Further research is warranted to explore the efficacy of reduced disulfiram dosage and multivitamin therapy in similar cases.
- Understanding the mechanisms behind this resolution could improve patient outcomes in alcohol dependence treatment.